News

For the first time in the week starting May 16th, Japan's three major pharmaceutical trade associations joined forces to call for changes to the government's drug pricing structure in order to prevent missing out on new drug innovation and...

Toppan, a global leader in communication, security, packaging, décor materials, and electronics solutions, has developed a thin, card-sized temperature logger label that enables temperature to be measured and recorded at regular intervals and data to be sent to a...

NetScientific plc, the international life sciences and sustainability technology investment and commercialisation Group announces that its wholly owned subsidiary ProAxsis has completed the development and validation of the AstraZeneca COVID-19 antibody test with “impressive performance evaluation results.” In June 2021...

Because of their inexpensive cost, vaccinations made with inactivated SARS-CoV-2 viruses are widely used in underdeveloped countries. As per new research from Sweden's Karolinska Institutet, a booster shot of mRNA vaccine given after two doses of inactivated vaccination provides...

 With high hopes, Eli Lilly's Mounjaro (tirzepatide) was promoted to the big leagues in the week ending May 14, when the FDA approved the type 2 diabetes and weight-loss medication. Can Lilly score a home run with a medicine...

Ardena, a fully integrated Contract Development and Manufacturing Organization (CDMO) assisting biopharma companies with services spanning all the development life cycle, has announced upgrades to its development and manufacturing facilities in Pamplona (Spain) with investments in dry granulation technology...

Pfizer is putting its substantial gain from COVID-19 drugs to good use by making deals. The company has decided it wants more, six months after partnering with Biohaven Pharma on a migraine medication. The Big Pharma will invest $11.6...